Phase 1 Advanced cancers Clinical Trials
5 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–5 of 5 trials
Recruiting
Phase 1
Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced Cancers
Advanced cancers
Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.42 enrolled11 locationsNCT07260708
Recruiting
Phase 1
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Colorectal, CancerMesothelin-Expressing TumorsEpithelial Ovarian Cancer+8 more
Context Therapeutics Inc.70 enrolled8 locationsNCT06756035
Recruiting
Phase 1
A Clinical Study of TQB3107 Tablets in Patients With Malignant Tumors
Advanced cancers
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.140 enrolled1 locationNCT06413953
Recruiting
Phase 1Phase 2
Plasmodium Immunotherapy for Advanced Cancers
Advanced cancers
CAS Lamvac Biotech Co., Ltd.20 enrolled1 locationNCT03375983
Active
Phase 1
Phase I study of RAD001 (Everolimus) in combination with Fluvastatin and Zoledronic acid in patients with solid tumours
Advanced cancers
St George Hospital25 enrolled1 locationACTRN12612000136808